Search research articles

お問い合わせ

JoVEについて

概要リーダーシップブログ JoVEヘルプセンター

著者向け

出版プロセス編集委員会範囲と方針査読よくある質問投稿

図書館員向け

推薦の声購読アクセスリソース図書館諮問委員会よくある質問

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments アーカイブ

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教員リソースセンター教員サイト

プライバシーポリシー

関連する概念動画

Non-equilibrium in the Cell

Non-equilibrium in the Cell

An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026

Same author

Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study.

American journal of hematology·2026

Same author

Artificial intelligence triage tool for bone marrow fibrosis in myeloproliferative neoplasms using complete blood counts.

The Lancet. Haematology·2026

Same author

JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost-Effectiveness Analysis.

American journal of hematology·2026

Same author

Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in <i>TP53</i>-Mutated Diffuse Large B-Cell Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Bringing the Teaching Close to Home: Implementation of a Near-Peer Model for Introductory Hematology-Oncology Fellowship Lecture Series.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026

Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026

Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026

Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026

Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026

Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026

Same journal

A step toward streamlining HIT diagnosis.

Blood·2026

関連記事をすべて見る

Search research articles

関連する実験動画

Updated: Sep 10, 2025

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

血液学における人工知能

Aziz Nazha¹, Olivier Elemento², Sanjay Ahuja³

¹Thomas Jefferson University, Cherry Hill, New Jersey, United States.

|August 22, 2025

まとめ

この要約は機械生成です。

人工知能 (AI) と機械学習 (ML) は,血液学における改善された診断とパーソナライズされた治療のための変革の可能性を提供します. しかし,データ品質,バイアス,規制の課題は,現在,これらの強力なツールの臨床採用を制限しています.

さらに関連する動画

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

関連する実験動画

Last Updated: Sep 10, 2025

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

科学分野:

血液学
人工知能 (AI)
機械学習 (ML)
生成性AI

背景:

血液学的疾患の診断と治療は,さまざまなデータ (イメージング,病理学,オミックス,ラボ) を統合することに依存しています.
データの量と複雑さが増加するにつれて臨床的意思決定が困難になっています
AI/MLは,診断の精度,リスクの分層化,治療の予測を向上させるための高度なモデリングを提供します.

研究の目的:

血液学におけるAI/MLの現状を2025年までに検討する.
臨床実務におけるAI/MLの実施における既存のギャップを特定する.
血液学におけるAIの将来の開発と応用に関する洞察を提供すること.

主な方法:

血液学におけるAI/MLにおける現在の文献と進歩のレビュー
治療戦略と診断ワークフローに対するGenerative AIの影響の分析
AI/MLツールの臨床実施を阻害する課題の特定

主要な成果:

AI/MLは診断からパーソナライズされた患者管理まで血液学に革命をもたらす大きな可能性を秘めています
ジェネラティブAIは新しい治療法,診断画像/レポート生成,患者ケアパーソナライゼーションを向上させることができます.
限られた臨床実施は,データ品質,公平性,インフラ,評価メトリックの課題に起因する.

結論:

人工知能とMLは血液学における大きな飛躍を意味します
バイアス,データ品質,規制上のギャップなどの重要な課題が普及を妨げています.
これらの課題に取り組むことは,臨床血液学におけるAIの潜在能力を完全に実現するために不可欠です.